Skip to main content

Topic

Vision Loss

36 published works

  1. Drug Injury Watch

    Syfovre Retinal Vaso-occlusive Vasculitis Case Report Involving 78-year Old Woman With Vision Loss

    By Tom Lamb

    She Went to the Local ER With Loss of Vision 11 Days After Receiving an Intravitreal Syfovre (Pegcetacoplan) Injection   (Posted by Tom Lamb at Drug Injury Watch)   In the March 2024…

  2. Drug Injury Watch

    Syfovre Eye Injury Cases: More Questions Than Answers One Year After First Reports

    By Tom Lamb

    Retinal Vasculitis After Syfovre Injections: Etiology is Still Unknown and Incidence Rate Remains Unclear   (Posted by Tom Lamb at Drug Injury Watch)   Syfovre (pegcetacoplan) was approved by the FDA in February…

  3. Bench & Bar of Minnesota

    I had a secret

    By Minnesota State Bar Association

    When I was in fourth grade I was shy and reserved. If you know me now, you might wonder how this was possible. But at the time, I was that…

  4. FB Employment Discrimination Blog

    Employers Should Not Turn A Blind Eye To Employees With Vision Disabilities

    By Amy Epstein Gluck

    Picture this: a young adult gets a new job at an upscale fish market. The adult, let’s call him Sam, tells his supervisor that while he wears contacts, he has…

  5. Kanoski Bresney Blog

    Personal Injury Claims for Accidents Resulting in Blindness or Vision Loss 

    By Kanoski Bresney Personal Injury Attorneys

    The ability to see is one ability that most people take for granted. Seeing allows us to drive, read, interact easily with computer screens and smartphones, and generally go about…

  6. Drug Injury Watch

    Beovu Drug Label Change in December 2021 Adds More Information About Vision Loss Side Effects

    By Tom Lamb

    Provides "risk factors and possible mechanism" for Beovu-related Retinal Vasculitis and Retinal Vascular Occlusion   (Posted by Tom Lamb at Drug Injury Watch)   We have finally seen the first Beovu drug label…

  7. Drug Injury Watch

    Elmiron-associated Retinopathy Risks Increased by (1) Longer Duration Use and (2) Higher Cumulative Dosage

    By Tom Lamb

    Elmiron Lawsuits Filed Because Drug Company Failed to Warn Before June 2020 About Elmiron-related Vision Loss Side Effects   (Posted by Tom Lamb at Drug Injury Watch)   We are handling Elmiron lawsuits…

  8. Searcy Law Blog

    Study Reveals Link Between Elmiron Exposure and Maculopathy

    By Searcy Law

    Elmiron (pentosan polysulfate sodium or PPS) is used to treat interstitial cystitis, a bladder condition that affects women more than men. Use of Elmiron has been linked to maculopathy, an…

  9. Drug Injury Watch

    Beovu Vision Loss Side Effects Continue to Plague Novartis, Ending 3 Key Clinical Trials in May 2021

    By Tom Lamb

    And Novartis "has yet to identify the root cause behind Beovu’s safety problem", According to a News Report   (Posted by Tom Lamb at Drug Injury Watch)   Starting back in February 2020,…

  10. Drug Injury Watch

    Elmiron Maculopathy Secondary to Pentosan Polysulfate (PPS) Toxicity: Medical Journal Article

    By Tom Lamb

    New Elmiron Study Suggests Established Maculopathy Patients Should be Asked About Possible Elmiron Use   (Posted by Tom Lamb at Drug Injury Watch)   Elmiron maculopathy secondary to pentosan polysulfate…